查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2097040

球蟲藥物市場－2026-2032年全球市場預測

Anticoccidial Drugs Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，球蟲藥物市場將成長至 3.8799 億美元，複合年成長率為 5.90%。

主要市場統計數據
基準年 2025 2.5973億美元
預計年份：2026年 2.7492億美元
預測年份 2032 3.8799億美元
複合年成長率 (%) 5.90%

球蟲藥是動物保健計畫中不可或缺的工具，用於預防和控制球蟲。球蟲是一種由埃米利亞屬（Emelia）寄生蟲引起的疾病，可感染家禽、牛、羊、山羊、豬和伴侶動物。在商業性家禽生產中，球蟲病仍然是最具經濟意義的腸道疾病之一，因為它會降低飼料轉換率、抑制體重增加、增加死亡率，並增加壞死性小腸結腸炎等繼發性感染的風險。為了在控制抗藥性風險的同時維持家禽群的生產力，該產業依賴離子載體、合成球蟲藥、複方製劑和策略性輪換用藥方案。

對高效球蟲藥物的需求受到多種因素的影響，包括蛋白質消費量的增加、家禽和牲畜生產的擴張、生物安全日益受到重視以及對肉類用抗菌藥物使用情況的嚴格審查。監管機構和獸醫部門越來越強調合理用藥、遵守殘留限量、停藥期以及綜合疾病管理。因此，生產者正從依賴藥物控制轉向更全面的球蟲管理策略，這些策略結合了診斷、疫苗接種、墊料管理、營養管理、農場衛生以及針對性球蟲藥物的使用。

球蟲藥物領域的變革性變化

隨著動物蛋白質生產商在提高生產力的同時，也要兼顧合理使用抗生素、滿足食品安全期望以及應對不斷變化的消費者偏好，球蟲藥物領域正在經歷結構性變革。離子載體類藥物因其在預防球蟲的既定作用，在許多家禽養殖系統中仍被廣泛使用，而合成化合物則繼續支持靶向干預和輪換策略。然而，長期暴露已降低了艾美球蟲族群的易感性，因此抗藥性監測和基於證據的輪換策略變得日益重要。

人工智慧球蟲藥物計畫的累積影響

人工智慧 (AI) 透過提高疾病監測、畜群監測和決策的準確性，對球蟲藥物策略的影響日益顯著。 AI 影像分析有助於及早發現墊料狀況、家禽活動、採食量、飲水量和生長模式的變化，這些變化可能預示著球蟲的風險，甚至在出現嚴重臨床症狀之前就能發現。將這些系統與農場感測器、環境控制系統和生產記錄相結合，有助於識別與卵囊積聚、腸道環境惡化和生產力下降相關的模式。

關於球蟲藥物的關鍵區域見解

亞太地區對球蟲病藥物的需求至關重要，因為該地區家禽生產強度高，對價格適中的動物蛋白需求不斷成長，且家禽養殖系統多樣，涵蓋了從高度一體化經營到小規模養殖的各種模式。由於家禽存欄大規模、氣候條件適宜卵囊存活以及農場球蟲生物安全措施的差異，中國和印度仍是該地區球球蟲防治的重點國家。日本、韓國和澳洲強調嚴格遵守殘留限量、加強獸醫監管和品質保證，而東南亞的生產商則擴大採用腸道健康和疫苗接種相結合的綜合策略，以支持出口導向型業務和國內家禽供應鏈。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

在東協地區，家禽消費量的成長、有利於卵囊存活的熱帶氣候以及向一體化生產系統的分階段過渡，都在影響球蟲藥物的使用。該地區各國正在加強獸醫監管、農場生物安全，並提高對藥物殘留的認知，同時支持國內需求和區域貿易。在海灣合作理事會（GCC）國家，糧食安全、現代化家禽生產和可控環境飼養備受重視，球蟲預防是家禽群健康管理計畫的關鍵組成部分，尤其是在高溫環境下，壓力反應會加劇腸道疾病的病情。

主要國家球蟲藥物的使用趨勢

美國在實施系統性的球蟲控制方案方面發揮了先鋒作用，在肉雞養殖場中採用輪作、穿梭養殖、疫苗接種、飼料監測和獸醫診斷等措施，以維持家禽生產力並滿足零售商主導的生產標準。在加拿大，動物用藥品的合理使用、對殘留限量的遵守以及動物福利都得到了重視。同時，墨西哥的家禽業優先考慮在溫暖、密集的生產環境中進行有效的疾病預防。在巴西的大規模家禽業中，整個大規模生產系統都依賴強力的球蟲控制措施，以維持飼料轉換率、符合出口標準並保障家禽健康。

為球蟲藥物行業的領導者提供的實用建議

產業領導者應透過整合獸醫診斷、藥物輪調計畫、疫苗接種、營養管理和農場衛生等綜合球蟲管理方案，提高球蟲藥的療效。定期進行病灶評分、糞便卵囊監測、生產性能基準測試以及球蟲藥的藥敏試驗，有助於及早發現療效下降的情況，並指導循證應對措施的實施。

調查方法

本執行摘要採用系統性的二手資料研究途徑編寫，重點檢驗、公開且有科學依據的資料資訊來源。該調查方法優先考慮來自獸醫監管機構、動物衛生部門、同行評審的寄生蟲學和家禽科學文獻、食品安全框架、官方殘留物管理指南以及公認的牲畜疾病控制資源的資訊。

結論

球蟲藥物在保護家禽和牲畜健康、提高飼料轉換率以及減少球蟲相關損失方面仍然發揮核心作用。然而，球蟲防治的未來發展方向正日益趨向於綜合性、數據驅動型和管理化。對抗藥性的擔憂、對食品安全的期望、消費者偏好以及監管監督等因素，促使生產者將球蟲藥物與疫苗接種、診斷、營養管理、環境管理和生物安全措施相結合。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：球蟲藥市場：依產品類型分類

  • 離子載體
    • 拉薩羅
    • 孟寧素
    • 沙利黴素
  • 合成藥物
    • 硝基呋喃類藥物
    • 奎諾酮藥物
    • 磺胺類藥物藥物

第8章：球蟲藥市場：依給藥途徑分類

  • 飼料添加劑
  • 飲用水管理
  • 口服
  • 注射藥物

第9章：球蟲藥市場：依動物類型分類

  • 家禽
  • 牛
  • 豬
  • 綿羊和山羊
  • 水產養殖

第10章：球蟲藥市場：依通路分類

  • 獸藥批發商
  • 飼料廠
  • 直銷
  • 獸藥
  • 畜牧業綜合經營者
  • 電子商務

第11章：球蟲藥市場：以最終用戶分類

  • 家禽養殖場
  • 畜牧場
  • 獸醫醫院和診所
  • 綜合生產商

第12章：球蟲藥市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：球蟲藥市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：球蟲藥市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Bioproperties Pty Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Cronus Pharma
  • Elanco Animal Health Inc.
  • Fengchen Group Co., Ltd.
  • Hipra Laboratories, SA
  • Huvepharma EOOD
  • Impextraco NV
  • Intas Pharmaceuticals Ltd.
  • Kaken Pharmaceutical Co. Ltd.
  • Kemin Industries Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Phibro Animal Health Corporation
  • Qilu Animal Health Products Co., Ltd.
  • Salius Pharma Pvt. Ltd.
  • TOKU-E
  • VH Group
  • Virbac Group
  • VIVAN Life Sciences Pvt. Limited
  • Zoetis Inc.
Product Code: MRR-456C7E8666FE

The Anticoccidial Drugs Market is projected to grow by USD 387.99 million at a CAGR of 5.90% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 259.73 million
Estimated Year [2026] USD 274.92 million
Forecast Year [2032] USD 387.99 million
CAGR (%) 5.90%

Anticoccidial drugs are essential tools in animal health programs designed to prevent and control coccidiosis, a parasitic disease caused by Eimeria species that affects poultry, cattle, sheep, goats, swine, and companion animals. In commercial poultry production, coccidiosis remains one of the most economically significant enteric diseases because it can impair feed conversion, reduce weight gain, increase mortality, and predispose flocks to secondary infections such as necrotic enteritis. The industry relies on ionophores, synthetic anticoccidials, combination products, and strategic rotation programs to sustain flock performance while managing resistance risks.

Demand for effective anticoccidial solutions is shaped by intensifying protein consumption, expansion of poultry and livestock production, biosecurity priorities, and growing scrutiny of antimicrobial use in food-producing animals. Regulatory agencies and veterinary authorities increasingly emphasize responsible use, residue compliance, withdrawal periods, and integrated disease management. As a result, producers are shifting from purely drug-dependent control toward broader coccidiosis management strategies that combine diagnostics, vaccination, litter management, nutrition, farm hygiene, and targeted anticoccidial administration.

Transformative Shifts in the Anticoccidial Drugs Landscape

The anticoccidial drugs landscape is undergoing a structural shift as animal protein producers balance productivity with antimicrobial stewardship, food safety expectations, and evolving consumer preferences. Ionophores remain widely used in many poultry systems due to their established role in coccidiosis prevention, while synthetic compounds continue to support targeted intervention and rotation strategies. However, long-term exposure has contributed to reduced sensitivity in Eimeria populations, making resistance monitoring and evidence-based rotation increasingly important.

Another transformative shift is the growing integration of anticoccidial drugs with non-drug control tools. Live and attenuated coccidiosis vaccines are being used in breeder, layer, and selected broiler programs to restore anticoccidial sensitivity and reduce reliance on continuous medication. Nutrition-based approaches, including gut health additives, enzymes, probiotics, prebiotics, organic acids, phytogenic compounds, and improved feed formulation, are being adopted to support intestinal resilience. At the farm level, better litter moisture control, stocking density management, ventilation, downtime sanitation, and biosecurity are becoming central to reducing oocyst cycling and disease pressure.

Regulatory and retail requirements are also reshaping product positioning. In regions where antibiotic reduction programs are prominent, producers are differentiating between medically important antibiotics and ionophore anticoccidials, while responding to "raised without antibiotics" and residue-free production standards. This has increased the need for clear labeling, veterinary oversight, compliance documentation, and transparent supply chain practices.

Cumulative Impact of Artificial Intelligence on Anticoccidial Programs

Artificial intelligence is increasingly influencing anticoccidial drug strategies by improving disease surveillance, flock monitoring, and decision-making precision. AI-enabled image analysis can support early detection of changes in litter condition, bird activity, feed intake, water consumption, and growth patterns that may indicate coccidiosis risk before severe clinical signs emerge. When integrated with farm sensors, environmental controls, and production records, these systems help identify patterns linked to oocyst buildup, gut health deterioration, and performance losses.

AI also strengthens veterinary analytics by enabling more accurate interpretation of fecal oocyst counts, lesion scoring data, mortality trends, and feed conversion metrics. Predictive models can support decisions on rotation timing, vaccination placement, medication withdrawal planning, and risk-based sampling. In feed mills and integrated production systems, machine learning can improve traceability and quality control by linking anticoccidial inclusion records, batch documentation, farm-level outcomes, and compliance audits.

The cumulative impact of artificial intelligence is not a replacement for veterinary judgment; it is a decision-support layer that helps reduce uncertainty. As datasets become more standardized and interoperable, AI can enable earlier intervention, more targeted anticoccidial use, stronger resistance management, and improved alignment with animal welfare and food safety objectives.

Key Regional Insights for Anticoccidial Drugs

Asia-Pacific is a critical region for anticoccidial drugs due to high poultry production intensity, rising demand for affordable animal protein, and diverse farming systems ranging from highly integrated operations to smallholder production. China and India remain central to regional coccidiosis control priorities because large poultry populations, climatic conditions favorable to oocyst survival, and variable farm biosecurity create persistent disease pressure. Japan, South Korea, and Australia emphasize stringent residue compliance, veterinary oversight, and quality assurance, while Southeast Asian producers are increasingly adopting integrated gut health and vaccination strategies to support export-oriented and domestic poultry supply chains.

North America is characterized by advanced poultry integration, sophisticated veterinary diagnostics, and strong attention to antimicrobial stewardship. In the United States and Canada, coccidiosis management is closely tied to broiler performance, animal welfare audits, feed program design, and evolving retail claims. Producers often use structured rotation and shuttle programs, vaccination cycles, and monitoring of anticoccidial sensitivity to preserve efficacy. Mexico's poultry and livestock sectors also depend on robust coccidiosis prevention, particularly in intensive production environments with warm climates that can elevate parasite challenge.

Latin America shows sustained reliance on anticoccidial drugs because poultry is a major source of animal protein and a key export category for several countries. Brazil plays a prominent role through large-scale poultry production, export quality systems, and emphasis on feed efficiency, while other regional markets focus on improving farm infrastructure, diagnostics, and responsible medication practices. Climatic variability, humidity, and differences in farm management make coccidiosis prevention a continuing priority.

Europe has one of the most closely regulated environments for veterinary medicinal products and feed additives, with strong focus on residue control, animal welfare, and reduced antimicrobial dependency. The European production model increasingly integrates vaccination, biosecurity, nutrition, and targeted medication. Producers in Germany, France, Italy, Spain, and the United Kingdom operate under high scrutiny from regulators, retailers, and consumers, which supports demand for transparent, evidence-based coccidiosis control programs.

The Middle East faces coccidiosis challenges linked to high-density poultry production, heat stress, water quality constraints, and the need for reliable food security systems. Gulf countries are investing in modern poultry facilities, veterinary monitoring, and feed quality systems, while import dependence in certain markets increases attention to residue standards and supply chain assurance. Africa presents a highly diverse landscape, with commercial poultry growth occurring alongside smallholder systems. Disease control is affected by access to veterinary services, feed quality, climate, and biosecurity limitations, making affordable and practical anticoccidial strategies important for poultry health and protein availability.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, anticoccidial drug use is influenced by expanding poultry consumption, tropical climates that support oocyst persistence, and a gradual shift toward integrated production systems. Countries in the bloc are strengthening veterinary oversight, farm biosecurity, and residue awareness as they support both domestic demand and regional trade. The GCC places strong emphasis on food security, modernized poultry production, and controlled-environment farming, making coccidiosis prevention a key component of flock health programs in high-temperature environments where stress can worsen enteric disease outcomes.

The European Union maintains a rigorous regulatory framework for veterinary products, feed additives, maximum residue limits, and official controls. This supports careful use of anticoccidials in combination with vaccination, surveillance, and animal welfare standards. BRICS countries represent diverse but influential animal protein systems. China, India, and Brazil are especially important due to large poultry populations and high production intensity, while Russia and South Africa face region-specific challenges linked to climate, production modernization, and veterinary access.

G7 countries generally demonstrate advanced veterinary infrastructure, strong diagnostic capacity, and heightened consumer attention to responsible drug use in food animals. These markets tend to prioritize traceability, compliance documentation, and integrated prevention programs. NATO countries overlap significantly with advanced poultry-producing economies in North America and Europe, where supply chain resilience, biosecurity, and regulatory harmonization influence anticoccidial procurement, use patterns, and monitoring practices.

Key Country Insights for Anticoccidial Drugs

The United States is a leading adopter of structured coccidiosis control programs, with broiler operations using rotation, shuttle programs, vaccination, feed monitoring, and veterinary diagnostics to maintain flock performance and meet retailer-driven production claims. Canada emphasizes responsible veterinary drug use, residue compliance, and animal welfare, while Mexico's poultry sector prioritizes practical disease prevention in warm and intensive production environments. Brazil's large poultry industry relies on strong coccidiosis management to sustain feed efficiency, export compliance, and flock health across high-volume production systems.

In Europe, the United Kingdom, Germany, France, Italy, and Spain operate within strict animal health and food safety expectations that encourage integrated coccidiosis management rather than sole dependence on continuous medication. The United Kingdom has placed strong emphasis on antimicrobial stewardship and assurance schemes, while Germany and France are associated with high veterinary oversight and consumer scrutiny. Italy and Spain combine intensive poultry production with attention to residue control, gut health management, and farm-level disease monitoring. Russia's poultry sector requires robust anticoccidial strategies due to large-scale production systems, climatic variation, and the need to maintain domestic protein supply.

China faces significant coccidiosis pressure due to the scale of poultry production and ongoing modernization of animal health systems, with increasing use of diagnostics, improved farm management, and regulated veterinary inputs. India's poultry industry is shaped by rapid protein demand growth, varied farm sizes, warm climates, and the need for accessible disease prevention tools. Japan and South Korea emphasize biosecurity, quality assurance, and residue control, aligning anticoccidial use with strict food safety expectations. Australia combines commercial poultry production with strong veterinary governance and biosecurity awareness, supporting disciplined use of anticoccidial drugs as part of broader flock health programs.

Actionable Recommendations for Anticoccidial Industry Leaders

Industry leaders should strengthen anticoccidial effectiveness through integrated coccidiosis management programs that combine veterinary diagnostics, rotation planning, vaccination, nutrition, and farm hygiene. Routine lesion scoring, fecal oocyst monitoring, performance benchmarking, and anticoccidial sensitivity testing can help identify reduced efficacy early and guide evidence-based interventions.

Producers and suppliers should prioritize antimicrobial stewardship by maintaining accurate medication records, respecting approved indications and withdrawal periods, training farm personnel, and aligning programs with national regulations and buyer requirements. Feed manufacturers should enhance quality assurance for anticoccidial inclusion, cross-contamination control, batch traceability, and documentation. Animal health stakeholders should also invest in digital monitoring platforms and AI-supported analytics to improve early detection, reduce unnecessary interventions, and support continuous improvement.

Strategically, the strongest programs will be those that treat anticoccidial drugs as one component of a broader gut health and biosecurity framework. Leaders should evaluate vaccine integration, optimize litter and ventilation management, support farmer education, and develop region-specific protocols that reflect climate, production system, Eimeria species prevalence, and regulatory expectations.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified, publicly available, and scientifically grounded sources. The methodology prioritizes information from veterinary regulatory agencies, animal health authorities, peer-reviewed parasitology and poultry science literature, food safety frameworks, official residue control guidance, and recognized livestock disease management resources.

Research inputs are assessed for relevance to coccidiosis epidemiology, anticoccidial drug classes, resistance management, veterinary stewardship, poultry and livestock production practices, regional regulatory environments, and integrated disease control. Insights are synthesized qualitatively to identify industry trends, regional dynamics, technology influences, and practical implications for producers, veterinarians, feed manufacturers, and animal health stakeholders. The analysis avoids market sizing, estimation, share calculation, and forecasting, and instead focuses on evidence-backed interpretation of disease control needs, regulatory direction, and operational best practices.

Conclusion

Anticoccidial drugs remain central to protecting poultry and livestock health, improving feed efficiency, and reducing losses associated with coccidiosis. However, the future of coccidiosis control is increasingly integrated, data-driven, and stewardship-focused. Resistance concerns, food safety expectations, consumer preferences, and regulatory oversight are encouraging producers to combine anticoccidial medication with vaccination, diagnostics, nutrition, environmental management, and biosecurity.

Regional and country-level needs vary widely, but the common priority is clear: maintaining effective control of Eimeria infections while supporting responsible drug use and sustainable animal protein production. Organizations that invest in evidence-based rotation programs, AI-enabled monitoring, traceable feed systems, and veterinary-led decision-making will be better positioned to improve flock outcomes and meet evolving industry standards.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Anticoccidial Drugs Market, by Product Type

  • 7.1. Introduction
  • 7.2. Ionophores
    • 7.2.1. Lasalocid
    • 7.2.2. Monensin
    • 7.2.3. Salinomycin
  • 7.3. Synthetic Drugs
    • 7.3.1. Nitrofurans
    • 7.3.2. Quinolones
    • 7.3.3. Sulfonamides

8. Anticoccidial Drugs Market, by Administration Mode

  • 8.1. Introduction
  • 8.2. Feed Additive
  • 8.3. Water Medication
  • 8.4. Oral Drench
  • 8.5. Injectable

9. Anticoccidial Drugs Market, by Animal Type

  • 9.1. Introduction
  • 9.2. Poultry
  • 9.3. Cattle
  • 9.4. Swine
  • 9.5. Sheep & Goats
  • 9.6. Aquaculture

10. Anticoccidial Drugs Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Veterinary Distributors
  • 10.3. Feed Mills
  • 10.4. Direct Sales
  • 10.5. Veterinary Pharmacies
  • 10.6. Livestock Integrators
  • 10.7. E-commerce

11. Anticoccidial Drugs Market, by End User

  • 11.1. Introduction
  • 11.2. Poultry Farms
  • 11.3. Livestock Farms
  • 11.4. Veterinary Hospitals & Clinics
  • 11.5. Integrated Producers

12. Anticoccidial Drugs Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Anticoccidial Drugs Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Anticoccidial Drugs Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Bioproperties Pty Ltd.
  • 16.2. Boehringer Ingelheim International GmbH
  • 16.3. Ceva Sante Animale
  • 16.4. Cronus Pharma
  • 16.5. Elanco Animal Health Inc.
  • 16.6. Fengchen Group Co., Ltd.
  • 16.7. Hipra Laboratories, S.A.
  • 16.8. Huvepharma EOOD
  • 16.9. Impextraco NV
  • 16.10. Intas Pharmaceuticals Ltd.
  • 16.11. Kaken Pharmaceutical Co. Ltd.
  • 16.12. Kemin Industries Inc.
  • 16.13. Merck & Co., Inc.
  • 16.14. Novartis AG
  • 16.15. Phibro Animal Health Corporation
  • 16.16. Qilu Animal Health Products Co., Ltd.
  • 16.17. Salius Pharma Pvt. Ltd.
  • 16.18. TOKU-E
  • 16.19. VH Group
  • 16.20. Virbac Group
  • 16.21. VIVAN Life Sciences Pvt. Limited
  • 16.22. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTICOCCIDIAL DRUGS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ANTICOCCIDIAL DRUGS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ANTICOCCIDIAL DRUGS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ANTICOCCIDIAL DRUGS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ANTICOCCIDIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL ANTICOCCIDIAL DRUGS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL ANTICOCCIDIAL DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IONOPHORES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IONOPHORES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IONOPHORES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LASALOCID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LASALOCID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LASALOCID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MONENSIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MONENSIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MONENSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SALINOMYCIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SALINOMYCIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SALINOMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SYNTHETIC DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SYNTHETIC DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SYNTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NITROFURANS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NITROFURANS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NITROFURANS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL QUINOLONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL QUINOLONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL QUINOLONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SULFONAMIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SULFONAMIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SULFONAMIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FEED ADDITIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FEED ADDITIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FEED ADDITIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL WATER MEDICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL WATER MEDICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL WATER MEDICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ORAL DRENCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ORAL DRENCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ORAL DRENCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SHEEP & GOATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SHEEP & GOATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SHEEP & GOATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FEED MILLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FEED MILLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FEED MILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LIVESTOCK INTEGRATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LIVESTOCK INTEGRATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LIVESTOCK INTEGRATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL E-COMMERCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL E-COMMERCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL E-COMMERCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL POULTRY FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL POULTRY FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL POULTRY FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL LIVESTOCK FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL LIVESTOCK FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL LIVESTOCK FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INTEGRATED PRODUCERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTEGRATED PRODUCERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INTEGRATED PRODUCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 150. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 151. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 152. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 174. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 175. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 176. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. NATO ANTICOCCIDIAL DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. NATO ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. NATO ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 182. NATO ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 183. NATO ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 184. NATO ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. NATO ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. NATO ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 199. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 200. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 201. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 207. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 208. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 209. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 215. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 216. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 217. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 231. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 232. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 233. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 239. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 240. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 241. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 247. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 248. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 249. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 255. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 256. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 257. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 259. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 263. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 264. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 265. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 279. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 280. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 281. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 283. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 287. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 288. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 289. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 291. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 295. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 296. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 297. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 299. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 301. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2032 (USD MILLION)
  • TABLE 303. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2032 (USD MILLION)
  • TABLE 304. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 305. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 307. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. GLOBAL ANTICOCCIDIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 309. GLOBAL ANTICOCCIDIAL DRUGS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025